Cynda(SH:603086) Ge Long Hui A P P·2026-01-26 08:23Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of 135 million to 155 million yuan for the year 2025, marking a turnaround from losses in the previous year [1] Financial Performance - The projected net profit for 2025 represents a significant improvement compared to the previous year, indicating a recovery in financial performance [1] - The expected net profit after deducting non-recurring gains and losses is estimated to be between 120 million and 140 million yuan [1] Product and Market Dynamics - The sales price of the company's main product, Acetochlor, has significantly increased compared to the same period last year, contributing to an overall improvement in product gross margins [1] - The successful launch and sales of the newly developed product series, Pyrazole, have further driven the growth of gross margins for domestic formulation products [1] Operational Efficiency - The company is continuously advancing operational reforms and implementing a gross profit distribution plan, which enhances cost and expense management [1] - Overall operational efficiency is improving as a result of these initiatives [1]